Calamos Strategic Total Return Fund Stock News

Baird Financial Group Inc. trimmed its position in Calamos Dynamic Convertible & Incm Fd (NASDAQ:CCD) by 5.2% during the 2nd quarter, according to the company in its most recent filing with the Securi

The Income Factory strategy of creating your own growth by reinvesting and compounding seemed pretty radical five years ago, and questions continue to arise as we add new readers.

For the fifth month in a row, equity CEFs on average posted positive returns, rising 2.71% on a NAV basis for August.

The recent downturn exposed the risk of high volatility and deep drawdowns with investing in closed-end funds. Obviously, they are not suited for everyone.

Calamos has 7 closed-end fund offerings for investors, primarily in their niche space of convertible investments.

Calamos Investments®* has announced monthly distributions and sources of distributions paid in August 2020 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective

Harry Domash is an income expert and editor of Dividend Detective. These top-performing funds (based on three-year returns) recently traded near their net asset values and are paying monthly dividends

The price of education can be steep. A good investing education will eventually pay off. Sometimes, you just don't know how something really works until you giv

Calamos Investments®* has announced monthly distributions and sources of distributions paid in July 2020 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective di

Analysts predict that Itamar Medical Ltd. (NASDAQ:ITMR) will report earnings of ($0.19) per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates

This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ

Guggenheim Capital LLC grew its position in shares of Calamos Dynamic Convertible & Incm Fd (NASDAQ:CCD) by 0.5% in the first quarter, according to its most recent filing with the SEC. The fund owned

Itamar Medical (NASDAQ:ITMR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Ita

Foresite Capital Management IV LLC increased its position in shares of Myokardia Inc (NASDAQ:MYOK) by 18.1% in the first quarter, Holdings Channel reports. The institutional investor owned 307,400 sha

In a market seemingly run by bored day traders, these securities remain largely out of reach of newbies, and they’re delivering some of best returns of 2020.